RT @Luis_Corral_Gud: Era cuestión de tiempo que llegasen ensayos clínicos de calidad. Hoy, por fin, NEJM nos deleita con uno sobre Remdesiv…
RT @khalid_eljaaly2: أخيرا تم نشر دراسة دواء #ريمديسيفير لعلاج #كوفيد١٩ #كورونا والتي أعلن عنها د. #فاوتشي سابقا ليس دواء عالي الفعالية ولك…
RT @jrarribas: El estudio del NIH ya está aquí Remdesivir for the Treatment of Covid-19 — Preliminary Report | NEJM https://t.co/OQncFYqnRG
RT @umarsaif: Very encouraging results for a drug soon to be manufactured in Pakistan. https://t.co/E6nFU2oSwe
RT @KiraNewmanMDPhD: #Remdesivir for #COVID19 RCT is finally out @NEJM! -Shorter time to recovery (11 v. 15 days in placebo group) -Lower m…
Clear benefit for COVID-19 patients (time to recovery) treated with $GILD remdesivir. 1st drug to demonstrate efficacy. Caveat: need to treat earlier, prior to intubation.
RT @DocDrMulasli: Remdesivir isimli ilacın işe yaramadığı ile ilgili bir çalışma yapılmıştı Çinliler tarafından... Başka bir grubun yaptığ…
@Fifoubraz @White_ganon @Tsarorius Sur le Remdesivir c'est sorti hier soir, et ça ne semble pas très efficace. https://t.co/GCSRixiIxf
Tid till tillfrisknande något kortare i Remdeaivir vs placebo. Men främst hos mindre sjuka pat. Ingen signifikant skillnad hos de i non-invasiv och invasiv ventilation. Ingen signifikant skillnad i dödlighet. https://t.co/NNY6HRCYS1
Remdesivir : 4 days faster recovery; 4.8% reduced mortality; Grade 3 or 4 adverse events 4.2% less common than placebo, but still present in 29% of COVID-19 patients. Still beats chloroquine sulfate. https://t.co/DWVckFprNp
RT @GaetanBurgio: #Remdesivir randomized control trial for #COVID19 from the @NIH just came out in @NEJM: - Shorter hospitalisation (11 v…
A small win. Govt ordered 607,000 #remdesivir. USA ordered 29 million #HydroxyChloroquine which doesn’t work COVIDー19 patients #capitalism #MedTwitter #healthcare @EricTopol @G
RT @Nat_anest: Ремдесивир: исследование #2 Наконец то было опубликованы те самые предварительные данные исследования на 1000+ пациентах,к…
A Randomised Clinical Trial showed that a 10-day course of IV remdesivir was superior to placebo in shortening the time to recovery. The estimates of mortality at 14 days were 7.1% in the remdesivir group and 11.9% in the placebo group. https://t.co/6qW09G
RT @YAYshamsaldeen: تابع السلسلة أعلاه النتائج المبدئية التي ظهرت اليوم على دواء 💉ريمديسيفير👇 https://t.co/4GajauzoNJ 🎥هي التي تطرقت لها…
RT @YAYshamsaldeen: شركة جيلياد تنشر نتائج أولية ل💉ريمديسيفير على1063شخص.. مبدئيا الدواء 💉يسرع -بشكل عام- التشافي 💉أفضل النتائج كانت مع من…
RT @drmiguelmarcos: Resultados del Remdesivir en el @NEJM No es ninguna maravilla y desde luego no hemos encontrado la "bala mágica", per…
Remdesivir for the Treatment of Covid-19 — Preliminary Report | NEJM https://t.co/rzZDsGBIiv
RT @KiraNewmanMDPhD: #Remdesivir for #COVID19 RCT is finally out @NEJM! -Shorter time to recovery (11 v. 15 days in placebo group) -Lower m…
RT @Nat_anest: Ремдесивир: исследование #2 Наконец то было опубликованы те самые предварительные данные исследования на 1000+ пациентах,к…
A Randomised Clinical Trial showed that a 10-day course of IV remdesivir was superior to placebo in shortening the time to recovery. The estimates of mortality at 14 days were 7.1% in the remdesivir group and 11.9% in the placebo group. https://t.co/6qW09G
「レムデシビル」に回復期間の短縮効果か 新型コロナ | NHKニュース https://t.co/w7LmsKSld6 論文はこちら。 Remdesivir for the Treatment of Covid-19 — Preliminary Report https://t.co/QYb3ofa8wQ
RT @EricTopol: The Remdesivir placebo-controlled randomized trial data. We've eagerly awaited the data; now published @NEJM https://t.co/zm…
RT @EricTopol: The Remdesivir placebo-controlled randomized trial data. We've eagerly awaited the data; now published @NEJM https://t.co/zm…
Ого, первое действительно работающее лекарство для covid! Очень хорошие новости
RT @jeremyfaust: Gut check. Would I, an ER doc, take: Remdesivir: Probably. Much yet to learn, but as of now, likely faster recovery +dec…
Thoughts on NIAID/ $GILD ACCT-1 #remdesivir study report: 1) good evidence for benefit; unclear though who benefits 2) unlike earlier Chinese paper, no benefit if randomized early vs late 3) NO VIRAL LOAD data shown 4) D-dimer at baseline not shown ht
RT @EricTopol: The Remdesivir placebo-controlled randomized trial data. We've eagerly awaited the data; now published @NEJM https://t.co/zm…
Remdesivir for the Treatment of Covid-19 — Preliminary Report | NEJM Remdesivir was superior to placebo in shortening the time to recovery in adults hospitalized with Covid-19 and evidence of lower respiratory tract infection. https://t.co/hQkj6Eg4At
@abhishekhare read this thread
אריק טופול מאמל"ק את המחקר של רמדסיביר
RT @Luis_Corral_Gud: Era cuestión de tiempo que llegasen ensayos clínicos de calidad. Hoy, por fin, NEJM nos deleita con uno sobre Remdesiv…
RT @fjpinto1960: Important data. Not the cure yet but certainly a relevant and significant step forward.
RT @bitacorabeagle: Estudio sobre el medicamento #remdesivir para tratar la #COVIDー19: "Beneficio significativo en el tiempo de recuperació…
RT @YAYshamsaldeen: شركة جيلياد تنشر نتائج أولية ل💉ريمديسيفير على1063شخص.. مبدئيا الدواء 💉يسرع -بشكل عام- التشافي 💉أفضل النتائج كانت مع من…
RT @mimilewissabin: Remdesivir for the Treatment of Covid-19 — Preliminary Report @nejm https://t.co/bZV8NyyMUK
#Remdesivir for the Treatment of #Covid_19 — Preliminary Report | @NEJM https://t.co/IyoP9b9d9A
RT @AndyBiotech: #COVID19 Biggest new info in #Remdesivir NIAID full data was no benefit in patients on mechanical ventilation or ECMO. Th…
RT @EricTopol: The Remdesivir placebo-controlled randomized trial data. We've eagerly awaited the data; now published @NEJM https://t.co/zm…
RT @drmiguelmarcos: Resultados del Remdesivir en el @NEJM No es ninguna maravilla y desde luego no hemos encontrado la "bala mágica", per…
RT @KiraNewmanMDPhD: #Remdesivir for #COVID19 RCT is finally out @NEJM! -Shorter time to recovery (11 v. 15 days in placebo group) -Lower m…
RT @ecapobianco: Good news re Remdesivir. Not the magic bullet against #COVIDー19, yet an apparently helpful tool to reduce length of hospit…
RT @DrEricDing: New: the NIH led Remdesivir trial with 1000 patients finally published. 11 days on R vs 15 days placebo: 32% faster rate of…
Estudio sobre el medicamento #remdesivir para tratar la #COVIDー19: "Beneficio significativo en el tiempo de recuperación para el 27% (excepto para los intubados). Reducción de mortalidad en un 30%. https://t.co/tECTEUxRzu https://t.co/OsqgqNHZg7
RT @EricTopol: The Remdesivir placebo-controlled randomized trial data. We've eagerly awaited the data; now published @NEJM https://t.co/zm…
Remdesivir for the Treatment of Covid-19 — Preliminary Report | NEJM https://t.co/51MyKRvnF1
RT @DrChoueiri: Remdesivir for the Treatment of Covid-19 RCT published now in @NEJM —effect is mostly on time to recovery #COVID19 https:…
RT @glaco64: Le terrain étant préparé, voici bien à propos l'étude sur le Remdesivir qui sort... https://t.co/UezKvt182w
RT @hewlett_angela: Nice to see the prelim #Remdesivir RCT results in print @UNMC_ID @unmc @NebraskaMed @NEJM https://t.co/UQtMLULSNu
RT @EricTopol: The Remdesivir placebo-controlled randomized trial data. We've eagerly awaited the data; now published @NEJM https://t.co/zm…
RT @EricTopol: The Remdesivir placebo-controlled randomized trial data. We've eagerly awaited the data; now published @NEJM https://t.co/zm…
Important data. Not the cure yet but certainly a relevant and significant step forward.
Preliminary data in @NEJM: Compared with Placebo, 10 days of treatment with the antiviral #Remdesivir resulted in significant shortening of time to clinical #recovery (~11 vs ~15 days). Descriptive reduction in mortality in the Remdesivir group. #COVID19
RT @jeremyfaust: Gut check. Would I, an ER doc, take: Remdesivir: Probably. Much yet to learn, but as of now, likely faster recovery +dec…
RT @EricTopol: The Remdesivir placebo-controlled randomized trial data. We've eagerly awaited the data; now published @NEJM https://t.co/zm…
RT @BogochIsaac: Remdesivir & the treatment of hospitalized patients with #COVID19: The drug helps. Recovery in 11 days with remdesivir v…
RT @EricTopol: The Remdesivir placebo-controlled randomized trial data. We've eagerly awaited the data; now published @NEJM https://t.co/zm…
Тред про ремдесевір
RT @DrEricDing: New: the NIH led Remdesivir trial with 1000 patients finally published. 11 days on R vs 15 days placebo: 32% faster rate of…
RT @Luis_Corral_Gud: Era cuestión de tiempo que llegasen ensayos clínicos de calidad. Hoy, por fin, NEJM nos deleita con uno sobre Remdesiv…
RT @FZores: On a donc un essai randomisé contrôlé (RCT) contre placebo dans la COVID19 avec le remdesivir. C'est encore un exemple qu'on…
RT @KiraNewmanMDPhD: #Remdesivir for #COVID19 RCT is finally out @NEJM! -Shorter time to recovery (11 v. 15 days in placebo group) -Lower m…
RT @EricTopol: The Remdesivir placebo-controlled randomized trial data. We've eagerly awaited the data; now published @NEJM https://t.co/zm…
RT @gpollara: Well, well, there's an early morning treat to wake to.... Preliminary findings of the ACTT-1 #Remdesivir RCT for #COVID19 in…
RT @KiraNewmanMDPhD: #Remdesivir for #COVID19 RCT is finally out @NEJM! -Shorter time to recovery (11 v. 15 days in placebo group) -Lower m…
RT @ariannahuerta: Remdesivir for the Treatment of Covid-19 — Preliminary Report | NEJM https://t.co/EmVzJkFFNW
RT @Nat_anest: Ремдесивир: исследование #2 Наконец то было опубликованы те самые предварительные данные исследования на 1000+ пациентах,к…
RT @luca__pani: Preliminary results of this trial suggest that a 10-day course of #remdesivir was superior to placebo in the treatment of h…
RT @EricTopol: The Remdesivir placebo-controlled randomized trial data. We've eagerly awaited the data; now published @NEJM https://t.co/zm…
RT @Nat_anest: Ремдесивир: исследование #2 Наконец то было опубликованы те самые предварительные данные исследования на 1000+ пациентах,к…
RT @EricTopol: The Remdesivir placebo-controlled randomized trial data. We've eagerly awaited the data; now published @NEJM https://t.co/zm…
RT @zchagla: The infamous NIAID study published by Fauci. Seen here: https://t.co/njlGckc4AP Big takeaways 1) Congratulations on organizi…
"Remdesivir was superior to placebo in shortening the time to recovery in adults hospitalized with Covid-19 and evidence of lower respiratory tract infection" https://t.co/6dlccbidTl
RT @GilbertDeray: Les effets du Remdesivir sont modestes avec une durée d’hospitalisation plus courte, rien sur la mortalité. Ce n’est pas…
RT @virolvlog: نتائج التجربة السريرية التي انتظرناها نشرت اليوم في NEJM. كما علمنا مسبقاً من البيان الصحفي، تفوق Remdesivir على الدواء الوه…
RT @FZores: On a donc un essai randomisé contrôlé (RCT) contre placebo dans la COVID19 avec le remdesivir. C'est encore un exemple qu'on…
RT @Nat_anest: Ремдесивир: исследование #2 Наконец то было опубликованы те самые предварительные данные исследования на 1000+ пациентах,к…
RT @jrarribas: El estudio del NIH ya está aquí Remdesivir for the Treatment of Covid-19 — Preliminary Report | NEJM https://t.co/OQncFYqnRG
RT @YAYshamsaldeen: شركة جيلياد تنشر نتائج أولية ل💉ريمديسيفير على1063شخص.. مبدئيا الدواء 💉يسرع -بشكل عام- التشافي 💉أفضل النتائج كانت مع من…
RT @AndyBiotech: #COVID19 Biggest new info in #Remdesivir NIAID full data was no benefit in patients on mechanical ventilation or ECMO. Th…
RT @GilbertDeray: Les effets du Remdesivir sont modestes avec une durée d’hospitalisation plus courte, rien sur la mortalité. Ce n’est pas…
Remdesevor preliminary report published showing a shortening of time to recovery in hospitalised patients with COVID-19 - nice to finally see some details Remdesivir for the Treatment of Covid-19 — Preliminary Report | NEJM https://t.co/7CBbERGZ2u
RT @Nat_anest: Ремдесивир: исследование #2 Наконец то было опубликованы те самые предварительные данные исследования на 1000+ пациентах,к…
RT @Luis_Corral_Gud: Era cuestión de tiempo que llegasen ensayos clínicos de calidad. Hoy, por fin, NEJM nos deleita con uno sobre Remdesiv…
RT @profilocomodo: Finalmente un trial randomizzato con controllo. Il Remdesevir è meglio del placebo. https://t.co/4TIS3WZWVi
تابع السلسلة أعلاه النتائج المبدئية التي ظهرت اليوم على دواء 💉ريمديسيفير👇 https://t.co/4GajauzoNJ 🎥هي التي تطرقت لها قبل ثلاثة أسابيع تقريبا في برنامج صحتك في رمضان عبر @atvkw رابط اللقاء الكامل👇 https://t.co/WeIkelRI8A (20) https://t.co/0jAY5pkCLl
RT @jrarribas: El estudio del NIH ya está aquí Remdesivir for the Treatment of Covid-19 — Preliminary Report | NEJM https://t.co/OQncFYqnRG
RT @ethanjweiss: The good: - we have a well-done placebo controlled RCT The great: - time from enrollement of 1st patient to full publi…
Selvä kliininen teho, RCT 1:1 ja riittävä otoskoko. Myös kuolleisuuden suhteen lupaava, kun katsoo luottamusvälejä. Remdesivir for the Treatment of Covid-19 — Preliminary Report | NEJM https://t.co/eMWZTbRCza
RT @FZores: On a donc un essai randomisé contrôlé (RCT) contre placebo dans la COVID19 avec le remdesivir. C'est encore un exemple qu'on…
RT @GilbertDeray: Les effets du Remdesivir sont modestes avec une durée d’hospitalisation plus courte, rien sur la mortalité. Ce n’est pas…
RT @Luis_Corral_Gud: Era cuestión de tiempo que llegasen ensayos clínicos de calidad. Hoy, por fin, NEJM nos deleita con uno sobre Remdesiv…
RT @EricTopol: The Remdesivir placebo-controlled randomized trial data. We've eagerly awaited the data; now published @NEJM https://t.co/zm…
Esperanzador. Si tenemos un nuevo brote empezaremos un ensayo clínico en niños también, para los pacientes hospitalizados.
RT @Nat_anest: Ремдесивир: исследование #2 Наконец то было опубликованы те самые предварительные данные исследования на 1000+ пациентах,к…